<DOC>
	<DOCNO>NCT02846064</DOCNO>
	<brief_summary>Ovarian cryopreservation one available option preserve fertility prior potentially sterilize treatment . In absence technique vitro folliculogenesis injection isolate ovarian follicle , tissue re-used autograft . In France , first live birth orthotopic ovarian transplantation , obtain Roux et al . 2009 . This clinical trial aim collect data efficiency graft term restoration ovarian function live birth . It also allow u carry patient follow-up ovarian tissue cryopreservation autograft achieve . In case neoplastic malignancy , minimal residual disease detection perform ovarian tissue , avoid risk cancer re-seeding .</brief_summary>
	<brief_title>Development Ovarian Tissue Autograft Order Restore Ovarian Function</brief_title>
	<detailed_description />
	<criteria>Patients underwent Ovarian tissue cryopreservation Premature ovarian failure Patients cure primary disease Women 18 43 year age Patients already benefited ovarian tissue autograft Patients trusteeship Patients place receiver Patients protection conservator</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>43 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>